- This event has passed.
Update on ECMO for COVID-19 Patients. Weaning – V-A ECMO with Cardiogenic Shock. Recombinant Activating Factor VII
October 6, 2021 @ 6:45 am - 10:00 am CDT$54
This Perfusion Meeting was approved for 3.6 Category 1 CEU by ABCP
Vanderbilt University Medical Center; Department of CV Surgery: Faculty Forum
Update on ECMO for COVID-19: What have we learned?
Faculty: J. Hoffman, MD, Matt Warhoover, CCP, A. Lepore, CCP
Tammy Sparacino Journal Club:
Early experience of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation (VA ECMO) in adult patients with cardiogenic shock.
Pump-controlled retrograde trial off has recently been introduced as an effective method for weaning from veno-arterial extracorporeal membrane oxygenation in pediatric patients.
However, studies on pump-controlled retrograde trial off in adults are still lacking. Thus, this study aimed to examine the outcomes of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation in adult patients.
John Ingram Knowledge Nuggets:
Recombinant Activated Human Factor VII
Register and watch for free @ https://library.perfusioneducation.com
Get our Perfusion App – https://perfusioneducation.com/perfusion-app/
IV Dosage and Rate Calculator – https://mediweb.us/iv-medication-calculator/
Subscribe to our podcast:
Apple Podcasts – https://podcasts.apple.com/us/podcast/the-perfweb-podcast/id1549315399
Google Podcasts – https://www.google.com/podcasts?feed=aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL3BlcmZ3ZWIvZmVlZC54bWw%3D
Spotify – https://open.spotify.com/show/7FWOk2uUVKpzvqK1sxz3Lt
© 2021 The New Orleans Conference - Online Edition. All Rights Reserved.